Last reviewed · How we verify
NCT02763020
Postprandial Glycemic Response to Polyphenol-fortified Snack Bars
NA trial testing Fruit extracts high in polyphenols in Blood Sugar Response in 20 participants. Completed in 1 November 2017.
1 October 2017
Quick facts
| Lead sponsor | United States Army Research Institute of Environmental Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 1 March 2016 |
| Primary completion | 1 October 2017 |
| Estimated completion | 1 November 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Fruit extracts high in polyphenols
- placebo
Conditions studied
- Blood Sugar Response — all drugs for Blood Sugar Response →
Sponsor
United States Army Research Institute of Environmental Medicine
Who can join
Adults 18 to 39, any sex, with Blood Sugar Response. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
blood glucose concentrations
Time frame: fasting and post-prandial (every 15 minutes for the first hour and every half hour for the last two hours)
Sponsor's own description
Consuming plant chemicals (e.g., polyphenols) may have beneficial effects on human health that, if confirmed, may warrant inclusion in combat rations. Ration developers would like to determine whether the fortification of a high sugar food item with a polyphenol-rich freeze-dried fruit and/or a fruit extract improves blood sugar response and promotes other positive physiological changes (e.g., satiety) in a dose-response manner. This study will test four different types of snack bar with various polyphenol doses, and compare blood response to a snack bar without polyphenols.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evidence-Based Anti-Diabetic Properties of Plant from the Occitan Valleys of the Piedmont Alps.
Boscaro V, Rivoira M, Sgorbini B, Bordano V, et al · · 2022 · cited 4× · PMID 36365189 · DOI 10.3390/pharmaceutics14112371
Verify or expand the search:
- PubMed search for NCT02763020
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other United States Army Research Institute of Environmental Medicine trials
Trials by the same sponsor.
- NCT07489690 — Energy Dense Fueling for Cold-Weather Operations · NA · recruiting
- NCT07099872 — Chronic Exercise With Overdressing · NA · completed
- NCT06468748 — The Effects of Semaglutide on Body Composition and Performance in Military Personnel · Phase 4 · withdrawn
- NCT07063173 — Bioavailability of Ration Items Containing Tart Cherry Extract · NA · recruiting
- NCT06073080 — Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02763020 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United States Army Research Institute of Environmental Medicine
- Last refreshed: 8 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02763020.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing